altona Diagnostics

𝗚𝗶𝗿𝗹𝘀’ 𝗮𝗻𝗱 𝗕𝗼𝘆𝘀’ 𝗗𝗮𝘆 𝟮𝟬𝟮𝟰: 𝗵𝗶𝗴𝗵 𝘀𝗰𝗵𝗼𝗼𝗹 𝘀𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝘃𝗶𝘀𝗶𝘁𝗲𝗱 𝗮𝗹𝘁𝗼𝗻𝗮 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 On April 25, we were happy to open our doors once again for young high school students on the occasion of Girls’ and Boys’ Day 2024. This German nationwide day of action is a fun and engaging way for girls and boys to have a sneak peek into various professions and industries and get excited about their future careers. After an introduction into biology and altona’s field of work, the students received a guided tour from altona scientist Helge Marquardt through our Research and Development department. They had an insight look into how a lab works, what kind of technology is used and, more specifically, what a diagnostic company does. Also, as a real hands-on experience, they isolated DNA from tomatoes and bananas and set up a PCR with the help of altona technical assistant Uli Eppinger. This way, they acquired an initial understanding of the lab technique PCR. altona is always on the lookout for talented and enthusiastic future team members. That is why we use this opportunity to inspire young people and introduce them to molecular diagnostics. We are looking forward to welcoming interested students again next year. #altonaDiagnostics #girlsandboysday

𝗩𝗶𝘀𝗶𝘁 𝗮𝗹𝘁𝗼𝗻𝗮 𝗼𝗻 𝗱𝗮𝘆 𝟯 𝗮𝗻𝗱 𝟰 𝗼𝗳 #𝗘𝗖𝗖𝗠𝗜𝗗 𝟮𝟬𝟮𝟰 After two inspiring exhibition days, altona Diagnostics is happy to welcome you also today, April 29, and tomorrow, April 30, at our booth 𝗕𝟯 𝗶𝗻 𝗛𝗮𝗹𝗹 𝟳. The first days of the ECCMID were filled with exciting presentations and interesting discussions in the field of molecular diagnostics. Our altona professionals enjoyed having valuable and fruitful exchanges with visitors about our AltoStar® automation system as well as our broad real-time PCR test portfolio. In case you have not yet had the chance to visit our booth, you still have two more days to stop by. Additionally, we invite you to our 𝗹𝘂𝗻𝗰𝗵 𝗴𝗮𝘁𝗵𝗲𝗿𝗶𝗻𝗴 𝗮𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵 𝘁𝗼𝗱𝗮𝘆, 𝗔𝗽𝗿𝗶𝗹 𝟮𝟵, 𝗮𝘁 𝟭𝟮 𝗻𝗼𝗼𝗻. You will have the opportunity to get to know our team and our solutions while enjoying some snacks. #ECCMID #Exhibition #Congress #MeetAndConnect #altonaDiagnostics

𝗩𝗶𝘀𝗶𝘁 𝗮𝗹𝘁𝗼𝗻𝗮 𝗮𝘁 𝘁𝗵𝗲 #𝗘𝗖𝗖𝗠𝗜𝗗 𝟮𝟬𝟮𝟰, 𝗔𝗽𝗿𝗶𝗹 𝟮𝟳-𝟯𝟬 We are excited about ECCMID 2024! Tomorrow is the first day, and we are in the final preparations to set up our booth and get everything ready for your visit! Stop by our booth B3 in Hall 7 and get a glimpse of our AltoStar® Molecular Diagnostic Worklow including the soon to be launched AI based automated result interpretation AltoStar® Analysis. Also, altona Diagnostics professionals will be pleased to provide you with more information on our broad real-time PCR test portfolio. We are looking forward to meeting you there from April 27-30. #ECCMID #Exhibition #Congress #MeetAndConnect #altonaDiagnostics

𝗮𝗹𝘁𝗼𝗻𝗮 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗲𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗠𝗮𝗹𝗮𝗿𝗶𝗮 April 25 is #WorldMalariaDay – time to raise awareness for this serious and often fatal disease that affected 249 million people and caused 608,000 deaths in 2022, according to the World Health Organization. This year WHO’s global public health campaign slogan is: “Accelerating the fight against malaria for a more equitable world.” There are five different 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 parasite species, the causative agents of Malaria, that infect humans, with 𝘗. 𝘧𝘢𝘭𝘤𝘪𝘱𝘢𝘳𝘶𝘮 and 𝘗. 𝘷𝘪𝘷𝘢𝘹 posing the greatest threat. These parasites are transmitted through the bites of infected female Anopheles mosquitoes. The 𝗥𝗲𝗮𝗹𝗦𝘁𝗮𝗿® 𝗠𝗮𝗹𝗮𝗿𝗶𝗮 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟬 enables the detection of 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘴𝘱𝘱. specific DNA, including the five human pathogenic species 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘧𝘢𝘭𝘤𝘪𝘱𝘢𝘳𝘶𝘮, 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘷𝘪𝘷𝘢𝘹, 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘮𝘢𝘭𝘢𝘳𝘪𝘢𝘦, 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘰𝘷𝘢𝘭𝘦, and 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘬𝘯𝘰𝘸𝘭𝘦𝘴𝘪. Additionally, the 𝗥𝗲𝗮𝗹𝗦𝘁𝗮𝗿® 𝗠𝗮𝗹𝗮𝗿𝗶𝗮 𝗦𝗰𝗿𝗲𝗲𝗻 & 𝗧𝘆𝗽𝗲 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟬 can be used to differentiate between these 5 Plasmodium species. Most cases occur in Africa, with children under the age of 5 being the most vulnerable group. However, significant numbers of cases and deaths are also reported in regions like South-East Asia, Eastern Mediterranean, Western Pacific, and the Americas. Malaria can affect anyone: even people from countries where the disease is not prevalent can become infected while traveling or through blood transfusion. Even mild cases of malaria can quickly progress to a severe illness, so early diagnosis and treatment are crucial.   #Malaria #FightMalaria #RealStar #altonaDiagostics

𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗻𝗼𝘄: 𝗥𝗲𝗮𝗹𝗦𝘁𝗮𝗿® 𝗡𝗶𝗩 & 𝗛𝗲𝗩 𝗥𝗧-𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟬 (𝗥𝗨𝗢) altona Diagnostics has recently launched the 𝗥𝗲𝗮𝗹𝗦𝘁𝗮𝗿® 𝗡𝗶𝗩 & 𝗛𝗲𝗩 𝗥𝗧-𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟬 𝗥𝗨𝗢. It is a reagent system based on real-time PCR technology for the qualitative detection and differentiation of Nipah virus (NiV) and Hendra virus (HeV) specific RNA. The kit complements our Fever, tropical & emerging (FTE) product panel and is for research use only (RUO). 𝗔𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝘃𝗶𝗿𝘂𝘀𝗲𝘀 𝗶𝗻 𝗴𝗲𝗻𝗲𝗿𝗮𝗹 The 𝗡𝗶𝗽𝗮𝗵 𝘃𝗶𝗿𝘂𝘀 was initially identified during an outbreak in Malaysia in 1998 and has since sparked sporadic outbreaks in South and Southeast Asia, resulting in severe respiratory disease and encephalitis in humans. The virus is thought to be transmitted to humans through contact with infected bats or contaminated fruit. Discovered in Australia in 1994, the 𝗛𝗲𝗻𝗱𝗿𝗮 𝘃𝗶𝗿𝘂𝘀 causes illnesses in horses and humans. Transmitted to humans through contact with infected horses or their bodily fluids, the Hendra virus can lead to severe respiratory and neurological symptoms. Both viruses have a high mortality rate, ranging from 40-70%, and there are currently no specific treatments available. Nipah and henipaviral diseases are on the World Health Organization R&D Blueprint, requiring ongoing surveillance and research to enhance understanding and control. #altonaDiagnostics #nipah #hendra #Launch #RUO #PCR

𝗠𝗲𝗲𝘁 𝗮𝗹𝘁𝗼𝗻𝗮 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝘁 𝘁𝗵𝗲 #𝗘𝗖𝗖𝗠𝗜𝗗 𝟮𝟬𝟮𝟰 altona Diagnostics is excited to attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain, from April 27-30, 2024! Come and visit us at our booth 𝗕𝟯, 𝗛𝗮𝗹𝗹 𝟳. This year we are thinking big and are welcoming you with our 63 sqm booth. There, we will promote our AltoStar® Molecular Diagnostic Worklow including the soon to be launched AI based automated result interpretation AltoStar® Analysis as well as our broad real-time PCR test portfolio. At the booth, altona professionals will keep you up to date on our solutions and new developments. Additionally, you are invited to our 𝗹𝘂𝗻𝗰𝗵 𝗴𝗮𝘁𝗵𝗲𝗿𝗶𝗻𝗴 𝗮𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵 𝗱𝘂𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝘂𝗻𝗰𝗵 𝗯𝗿𝗲𝗮𝗸 𝗼𝗻 𝗔𝗽𝗿𝗶𝗹 𝟮𝟵 (𝘀𝘁𝗮𝗿𝘁: 𝟭𝟮 𝗻𝗼𝗼𝗻). You will have the opportunity to get to know our team and our solutions while enjoying some snacks. With over 16,000 participants from all over the world and more than 140 exhibitors, ECCMID brings together experts from many fields. It is going to be a productive and enriching event. #ECCMID #Exhibition #Congress #MeetAndConnect #altonaDiagnostics

𝗮𝗹𝘁𝗼𝗻𝗮 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗶𝘀 𝗰𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗳𝗶𝗴𝗵𝘁𝗶𝗻𝗴 𝗖𝗵𝗮𝗴𝗮𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 World Chagas Disease Day is held on April 14. This awareness day is part of an official global public health campaign marked by the World Health Organization. The theme for 2024 is: “𝗧𝗮𝗰𝗸𝗹𝗶𝗻𝗴 𝗖𝗵𝗮𝗴𝗮𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲: 𝗱𝗲𝘁𝗲𝗰𝘁 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗹𝗶𝗳𝗲”. Chagas is a neglected tropical disease and is endemic in approximately 21 countries in the Americas. It is transmitted by kissing bugs and caused by 𝘛𝘳𝘺𝘱𝘢𝘯𝘰𝘴𝘰𝘮𝘢 𝘤𝘳𝘶𝘻𝘪, a protozoan parasite. To help in the fight against Chagas disease, altona Diagnostics offers the 𝗥𝗲𝗮𝗹𝗦𝘁𝗮𝗿® 𝗖𝗵𝗮𝗴𝗮𝘀 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟬, an 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 diagnostic test for detecting 𝘛𝘳𝘺𝘱𝘢𝘯𝘰𝘴𝘰𝘮𝘢 𝘤𝘳𝘶𝘻𝘪 specific DNA. Currently, 6-7 million people worldwide are infected with 𝘛. 𝘤𝘳𝘶𝘻𝘪. While the disease is curable if caught early, it can be deadly if left untreated. Testing is crucial as 70-80% of infections are asymptomatic and can be transmitted from mother to child in pregnancy (congenital Chagas disease). For more information and purchasing options of the RealStar® Chagas PCR Kit 1.0 contact our Argentine or Brazilian subsidiaries (altona Diagnostics Argentina SRL, altona Diagnostics Brasil) or browse through our worldwide sales and distributor list: https://lnkd.in/erc6Ee98 #Chagas #NeglectedDiseases #RealStar #altonaDiagnostics

𝗡𝗲𝘄 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗠𝗮𝗻𝗮𝗴𝗲𝗿𝘀 𝗳𝗼𝗿 𝗮𝗹𝘁𝗼𝗻𝗮 𝗔𝗿𝗴𝗲𝗻𝘁𝗶𝗻𝗮 𝗮𝗻𝗱 𝗮𝗹𝘁𝗼𝗻𝗮 𝗕𝗿𝗮𝘇𝗶𝗹 On April 1, 2024, founding manager Hans Kuhn handed over the management of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos Aires and São Paulo to take on a position at the altona headquarters in Hamburg, Germany. The new General Managers Mariela Aranda for altona Diagnostics Argentina SRL and Julianna Shibao for altona Diagnostics Brasil both have an extensive experience in the IVD market – Mariela with a career in the pharmaceutical industry and in regulatory affairs of medical products, and Julianna with a focus on diagnostics, sales, and marketing. Hans declares: “I am leaving with a full bag of incredible experiences having steered the companies through the past 6 years – including a pandemic! And I know that both successors are the perfect fit to lead dedicated teams of professionals pushing altona Diagnostics Argentina and Brazil to the next stage of their development”. #altonaDiagnostics #Brazil #Argentina #GeneralManagement

𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗻𝗼𝘄: 𝗔𝗹𝘁𝗼𝗦𝘁𝗮𝗿® 𝗖. 𝗮𝘂𝗿𝗶𝘀 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟱 (𝗥𝗨𝗢) altona Diagnostics has launched the 𝗔𝗹𝘁𝗼𝗦𝘁𝗮𝗿® 𝗖. 𝗮𝘂𝗿𝗶𝘀 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟱 (𝗥𝗨𝗢), a reagent system for the qualitative detection of 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 𝘢𝘶𝘳𝘪𝘴 specific DNA, complementing our AltoStar® immunocompromised product portfolio. It is designed for use with the automated AltoStar® Workflow, which offers enhanced flexibility in sample-to-PCR management. The kit is for research use only (RUO).   Along with the 𝗔𝗹𝘁𝗼𝗦𝘁𝗮𝗿® 𝗣𝗻𝗲𝘂𝗺𝗼𝗰𝘆𝘀𝘁𝗶𝘀 𝗷𝗶𝗿𝗼𝘃𝗲𝗰𝗶𝗶 𝗣𝗖𝗥 𝗞𝗶𝘁 𝟭.𝟱 (𝗥𝗨𝗢), the new AltoStar® C. auris PCR Kit 1.5 (RUO) is the second PCR assay of the AltoStar® product line for the detection of fungal DNA.   𝗔𝗯𝗼𝘂𝘁 𝘾𝙖𝙣𝙙𝙞𝙙𝙖 𝙖𝙪𝙧𝙞𝙨 𝗶𝗻 𝗴𝗲𝗻𝗲𝗿𝗮𝗹 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 𝘢𝘶𝘳𝘪𝘴 is an emerging multidrug resistant yeast with the ability to persist and spread easily within healthcare and intensive care settings. It can cause severe bloodstream and wound infections, particularly in immunocompromised and hospitalized patients leading to high mortality rates. The World Health Organization and Centers for Disease Control and Prevention have classified C. auris as a critical threat to public health.   #Cauris #PCR #Launch #AltoStar #altonaDiagnostics

𝗮𝗹𝘁𝗼𝗻𝗮 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗶𝘀 𝗼𝗻𝗲 𝗼𝗳 “𝗛𝗮𝗺𝗯𝘂𝗿𝗴’𝘀 𝗕𝗲𝘀𝘁 𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗿𝘀 𝟮𝟬𝟮𝟰” For the first time, altona Diagnostics took part in the evaluation “Hamburg’s Best Employers” and received the prestigious seal right away. Over a decade, the award has been a key indicator for outstanding employers in the Hamburg metropolitan region. altona employees on all professional levels anonymously filled out a survey, giving feedback on the factors of strategy, structure, collaboration, leadership, health promotion, work and family, personal stress, and digitalization. Based on the results, altona has been elected as one of only 20 companies in Hamburg to be awarded the seal “Hamburg’s Best Employers 2024”. In addition to the certificate, the winning companies have their logo prominently displayed on several public transport buses driving through Hamburg. altona Diagnostics is proud to have earned this award, indicating a high level of satisfaction among altona employees. If you want to become part of the altona team and “join the dots”, discover our job offers: https://lnkd.in/eeDV2TCs #altonaDiagnostics #BestEmployer2024 #altonaSpirit #jointhedots